In addition, pDCs also display tolerogenic phenotypes, which are suggested to promote tumour development, including indoleamine 2,3‐dioxygenase expression in tumour‐draining lymph nodes 21 and induction of regulatory T‐cell expansion in breast cancer 22. This evidence concerns the gene IDO2 and neoplasm.